Bicyclic Pyridin-2-one and pyrimidin-4-one Derivatives Useful As a Factor XIa Inhibitors
申请人:Janssen Pharmaceutica NV
公开号:US20230183233A1
公开(公告)日:2023-06-15
The present invention is directed to bicyclic pyridinon-2-one and pyrimidin-4-one derivatives, stereoisomers, isotopologues, and pharmaceutically acceptable salts thereof, pharmaceutical compositions containing said compounds and the use of said compounds in the treatment and/or prophylaxis of thromboembolic disorders, inflammatory disorders and diseases or conditions in which plasma kallikrein activity is implicated.
L'abbe, Gerrit; Bastin, Lieve; Dehaen, Wim, Journal of the Chemical Society. Perkin transactions I, <hi>1992</hi>, # 14, p. 1755 - 1758